L&C Bio Co. Ltd (290650) - Total Liabilities
Based on the latest financial reports, L&C Bio Co. Ltd (290650) has total liabilities worth ₩231.24 Billion KRW (≈ $156.71 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of L&C Bio Co. Ltd to track the company's year-over-year net asset growth rate.
L&C Bio Co. Ltd - Total Liabilities Trend (2015–2024)
This chart illustrates how L&C Bio Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 290650 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
L&C Bio Co. Ltd Competitors by Total Liabilities
The table below lists competitors of L&C Bio Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RIAMB (Beijing) Tech Dvlp Co
SHG:603082
|
China | CN¥3.09 Billion |
|
Yueyang Forest & Paper Co Ltd
SHG:600963
|
China | CN¥12.77 Billion |
|
Rastar Group
SHE:300043
|
China | CN¥2.51 Billion |
|
Arctech Solar Holding Co Ltd
SHG:688408
|
China | CN¥5.66 Billion |
|
JOST Werke AG
XETRA:JST
|
Germany | €1.27 Billion |
|
SG Fleet Group Ltd
AU:SGF
|
Australia | AU$2.91 Billion |
|
Aerosun Corp
SHG:600501
|
China | CN¥2.60 Billion |
|
Morguard Corporation
TO:MRC
|
Canada | CA$7.15 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down L&C Bio Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of L&C Bio Co. Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how L&C Bio Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for L&C Bio Co. Ltd (2015–2024)
The table below shows the annual total liabilities of L&C Bio Co. Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩191.25 Billion ≈ $129.61 Million |
+65.89% |
| 2023-12-31 | ₩115.29 Billion ≈ $78.13 Million |
+13.28% |
| 2022-12-31 | ₩101.77 Billion ≈ $68.97 Million |
+354.74% |
| 2021-12-31 | ₩22.38 Billion ≈ $15.17 Million |
-1.71% |
| 2020-12-31 | ₩22.77 Billion ≈ $15.43 Million |
+183.10% |
| 2019-12-31 | ₩8.04 Billion ≈ $5.45 Million |
+63.60% |
| 2018-12-31 | ₩4.92 Billion ≈ $3.33 Million |
+33.68% |
| 2017-12-31 | ₩3.68 Billion ≈ $2.49 Million |
-34.81% |
| 2016-12-31 | ₩5.64 Billion ≈ $3.82 Million |
+8.52% |
| 2015-12-31 | ₩5.20 Billion ≈ $3.52 Million |
-- |
About L&C Bio Co. Ltd
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea.